Evidence map›Paper›PMID 31135059›Full record

ArticleThe Journal of pathology2019

Mitochondrial dysfunction and role of harakiri in the pathogenesis of myositis.

Jessica F Boehler, Adam Horn, James S Novak, Ning Li, Svetlana Ghimbovschi, Ingrid E Lundberg, Helene Alexanderson, Li Alemo Munters, Jyoti K Jaiswal, Kanneboyina Nagaraju

Abstract read
In one paragraph

Article in The Journal of pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Ferroptosis and its role in skeletal muscle diseases.Frontiers in molecular biosciences · 2022
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jessica F BoehlerCenter for Genetic Medicine Research, Children's National Health System, Washington, DC, USA.
Adam HornCenter for Genetic Medicine Research, Children's National Health System, Washington, DC, USA.
James S NovakCenter for Genetic Medicine Research, Children's National Health System, Washington, DC, USA.ORCID 0000-0002-9989-8724
Ning LiDepartment of Pharmaceutical Sciences School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, USA.
Svetlana GhimbovschiCenter for Genetic Medicine Research, Children's National Health System, Washington, DC, USA.
Ingrid E LundbergDivision of Rheumatology, Department of Medicine, Karolinska Institutet, Solna, Sweden.
Helene AlexandersonFunction Area Occupational Therapy and Physical Therapy, Karolinska University Hospital, Stockholm, Sweden.
Li Alemo MuntersFunction Area Occupational Therapy and Physical Therapy, Karolinska University Hospital and Swedish Rheumatism Association, Stockholm, Sweden.
Jyoti K JaiswalCenter for Genetic Medicine Research, Children's National Health System, Washington, DC, USA.
Kanneboyina NagarajuCenter for Genetic Medicine Research, Children's National Health System, Washington, DC, USA.
Children's National · USKarolinska University Hospital · SEBinghamton University · US

Funding

Research_ProjectU54HD090257 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI VITTORIO GALLO, VITTORIO GALLO VITTORIO GALLO · 2016 to 2020
$5.9M
Understanding the mechanism and role of cell membrane repair in Miyoshi MyopathyR01AR055686 · NIAMS · ROCKEFELLER UNIVERSITY · PI JAISWAL, JYOTI K · 2008 to 2021
$3.6M
Virus induced genetic changes in the pathogenesis of autoimmune myositisR21AI128248 · NIAID · STATE UNIVERSITY OF NY,BINGHAMTON · PI NAGARAJU, KANNEBOYINA · 2017 to 2018
$437k
Preclinical drug trial in mouse models of inflammationK26OD011171 · OD · STATE UNIVERSITY OF NY,BINGHAMTON · PI NAGARAJU, KANNEBOYINA · 2012 to 2015
$420k
Dystrophin turnover after exon-skippingR56NS097229 · NINDS · STATE UNIVERSITY OF NY,BINGHAMTON · PI NAGARAJU, KANNEBOYINA, PARTRIDGE, TERENCE A · 2016 to 2016
$390k
King Gustaf V 80 year FoundationMyositis Association and The US Department of Defense W81XWH-11-1-0809NIAID NIH HHS R21 AI128248NIAMS NIH HHS R01 AR055686NICHD NIH HHS U54 HD090257NIH HHS K26 OD011171NIH HHS R01AR55686NIH HHS R21AI128248NIH HHS R21AI128248-02NIH HHS R56NS097229-01NINDS NIH HHS R56 NS097229Stockholm County Council (ALF project)Swedish Research Council K2014-52X-14045-14-3Swedish Rheumatism AssociationTelethon
6 · The paper itself

Abstract

The etiology of myositis is unknown. Although attempts to identify viruses in myositis skeletal muscle have failed, several studies have identified the presence of a viral signature in myositis patients. Here we postulate that in individuals with susceptible genetic backgrounds, viral infection alters the epigenome to activate the pathological pathways leading to disease onset. To identify epigenetic changes, methylation profiling of Coxsackie B infected human myotubes and muscle biopsies from polymyositis (PM) and dermatomyositis (DM) patients were compared to changes in global transcript expression induced by in vitro Coxsackie B infection. Gene and protein expression analysis and live cell imaging were performed to examine the mechanisms. Analysis of methylation and gene expression changes identified that a mitochondria-localized activator of apoptosis - harakiri (HRK) - is upregulated in myositis skeletal muscle cells. Muscle cells with higher HRK expression have reduced mitochondrial potential and poor ability to repair from injury as compared to controls. In cells from myositis patient toll-like receptor 7 (TLR7) activates and sustains high HRK expression. Forced over expression of HRK in healthy muscle cells is sufficient to compromise their membrane repair ability. Endurance exercise that is associated with improved muscle and mitochondrial function in PM and DM patients decreased TLR7 and HRK expression identifying these as therapeutic targets. Increased HRK and TLR7 expression causes mitochondrial damage leading to poor myofiber repair, myofiber death and muscle weakness in myositis patients and exercise induced reduction of HRK and TLR7 expression in patients is associated with disease amelioration. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Indexed as

Apoptosis Regulatory ProteinsCase-Control StudiesCells, CulturedDermatomyositisDNA MethylationEnterovirus B, HumanEpigenesis, GeneticHost-Pathogen InteractionsHumansImmunity, InnateMitochondria, MuscleMuscle, SkeletalMuscle StrengthMyoblasts, SkeletalPhysical EndurancePolymyositisApoptosis Regulatory ProteinsHRK protein, humanTLR7 protein, humanToll-Like Receptor 7harakirimembrane repairmitochondriamuscle weaknessMyositistoll like receptors

Identifiers

PMID31135059
PMCPMC7219509
OpenAlexW2948017193

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.